We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current EPRX market cap is 118.95M. The company's latest EPS is USD -1.0344 and P/E is -4.22.
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -2.25M | -18.68M | -23.2M | -27.85M |
| Net Income | -4.01M | -22.99M | -23.26M | -28.22M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD (US$) | |
| Total Assets | 1.45M | 31.22M | 25.88M | 20.27M |
| Total Liabilities | 23.12M | 11.67M | 14.51M | 19.37M |
| Total Equity | -21.66M | 19.55M | 11.36M | 892k |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD (US$) | |
| Operating | -404k | -14.64M | -18.78M | -20.68M |
| Investing | 25k | -14.45M | 8.7M | -73k |
| Financing | -627k | 49.92M | 13.52M | 21.01M |
| Market Cap | 118.95M |
| Price to Earnings Ratio | -4.22 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.15 |
| Price to Book Ratio | 133.35 |
| Dividend Yield | - |
| Shares Outstanding | 27.28M |
| Average Volume (1 week) | 14.81k |
| Average Volume (1 Month) | 11.03k |
| 52 Week Change | -16.15% |
| 52 Week High | 7.64 |
| 52 Week Low | 3.07 |
| Spread (Intraday) | 0.08 (1.82%) |
| Company Name | Eupraxia Pharmaceuticals Inc |
| Address |
201 - 2067 cadboro bay road victoria, british columbia V8R 5G4. |
| Website | https://www.eupraxiapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
